Xiromed intros generic EnablexEnablex and its generics had a market value of $11.2 million for the 12-month period ended February 2021, according to IQVIA. Hikma debuts docetaxel injectionDocetaxel injection had a market value of roughly $10 million in the 12 months ended March 2021, according to IQVIA. Alembic intros nystatin and triamcinolone acetonide cream Alembic's generic nystatin and triamcinolone acetonide cream provides a treatment for cutaneous candidiasis. Elite, Prasco launch loxapine capsules Elite's loxapine succinate capsules provide treatment for schizophrenia. Teva intros erythromycin tablets Erythromycin oral tablets had a market value of more than $49 million, according to January 2021 IQVIA data. Amphastar obtains FDA OK for morphine sulfate injection Amphastar has sold and marketed under the "grandfather" exemption to the FDA's "Prescription Drug Wrap-Up" program. Sun Pharma launches authorized generic of Absorica Sun’s isotretinoin capsules are available in dosage strengths of 10 mg, 20 mg, 25 mg, 30 mg 35 mg and 40 mg. Teva launches 1st generic of Absorica Isotretinoin capsules had annual U.S. sales of more than $158 million for the year ended February 2021, according to IQVIA data. AAM supports introduction of Protecting Access to Affordable Medicines Act The Protecting Access to Affordable Medicines Act helps ensure patients maintain uninterrupted access to low-cost medicines. Q&A: Accord Healthcare’s Jeff Hampton highlights the generics supplier’s expertise Accord Healthcare's president talked to DSN about the state of the generics industry and how his company differentiates itself in a crowded and increasingly complex field. First Previous 118 119 120 121 122 Next Last
